Cline Scientific
Cline Scientific receives Decision to Grant for StemCART in Europe
The patent application is titled "A method for providing a cartilage implant with chondrocytes". The decision will take effect from the 14th of June 2023.
The notice of allowance for this patent was received from EPO and a press release was sent out in April.
More about StemCART
StemCART is a preclinical Advanced Therapy Medicinal Product (ATMP) that aims to revolutionize the treatment of cartilage damage for patients worldwide.
For more information, please contact:
Hanne Evenbratt, Interim CEO and VP – Research & Development
Email: hanne.evenbratt@clinescientific.com
Phone: +46 704 88 79 23
| Datum | 2023-05-23, kl 14:50 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!